Lv52
904 积分 2024-03-13 加入
A neomorphic protein interface catalyzes covalent inhibition of RAS G12D aspartic acid in tumors
2小时前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
1天前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
1天前
已完结
Nitroso Impurities in Drug Products: An Overview of Risk Assessment, Regulatory Milieu, and Control Strategy
23天前
已完结
SpaceExpander: An Automated System for Drafting Markush Claims to Expand Chemical Space
1个月前
已完结
AI-assisted interpretation of Markush structures in pharmaceutical patents: a review of emerging tools, datasets, and challenges
1个月前
已完结
QBD-driven HPLC method of eltrombopag olamine: Degradation pathway proposal, structure elucidation, and in silico toxicity prediction
1个月前
已完结
Apotex wins latest round in generic Paxil litigation
1个月前
已完结
Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study
1个月前
已完结
Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates
2个月前
已完结
皖公网安备34019202002308
